Linked research, clinical, and regulatory source pathways.
Company profile
About BrightHeart
AI-powered platform for fetal ultrasound analysis supporting exam completeness and clinical interpretation.
Company description BrightHeart official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at BrightHeart?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
No customer types are currently listed.
Deployment & integration
Deployment information is currently being developed.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · Sep 1, 2026
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · Sep 1, 2026
Use of Artificial Intelligence-Based Software to Aid in the Identification of Ultrasound Findings Associated With Fetal Congenital Heart Defects.Obstetrics and gynecology · Jan 1, 2026
Artificial Intelligence for the Detection of Fetal Ultrasound Findings Concerning for Major Congenital Heart Defects.Obstetrics and gynecology · Jan 1, 2026
Cancer immunotherapy.The Veterinary clinics of North America. Small animal practice · May 1, 2010
Cancer immunotherapy.Topics in companion animal medicine · Aug 1, 2009
Clinical validation
Clinical-trial records
Fetal Heart Ultrasound Suspicious Radiographic Finding Identification - Reader StudyNCT06392555 · Sponsor · COMPLETED
Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery DiseaseNCT03207646 · Mentioned · TERMINATED
Regulatory
Regulatory records
Fetal EchoScan (v1.2)K252294 · 510k · Dec 8, 2025
BrightHeart View ClassifierK251456 · 510k · Jun 5, 2025
BrightHeart View ClassifierK243684 · 510k · May 7, 2025
Fetal EchoScan (v1.1)K251071 · 510k · May 2, 2025
Fetal EchoScanK242342 · 510k · Nov 14, 2024
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from BrightHeart
Recent articles published on BrightHeart's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
No official links are currently listed.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.